Cargando…
Cabozantinib and apixaban: an hitherto unreported interaction
The use of direct oral anticoagulant in cancer patients is an emerging issue, which seems to be an alternative to low molecular weight heparin. Every year several new drugs are approved as anticancer treatment with possible drug-drug interaction with other drugs such as oral anticoagulant. We descri...
Autores principales: | Santini, Daniele, Citarella, Fabrizio, Vincenzi, Bruno, Russano, Marco, Tonini, Giuseppe, Stellato, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737677/ https://www.ncbi.nlm.nih.gov/pubmed/31528502 http://dx.doi.org/10.1186/s40164-019-0146-9 |
Ejemplares similares
-
Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
por: Russano, Marco, et al.
Publicado: (2020) -
Response to: Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
por: Citarella, Fabrizio, et al.
Publicado: (2021) -
Paroxetine-induced multifocal fixed drug rash: An incident, hitherto unreported
por: Das, Anupam, et al.
Publicado: (2017) -
Facing SARS-CoV-2 outbreak in immunotherapy era
por: Citarella, Fabrizio, et al.
Publicado: (2020) -
Steroid-refractory immune related hepatitis may hide viral re-activation
por: Citarella, Fabrizio, et al.
Publicado: (2020)